Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.

Pulaski BA, Clements VK, Pipeling MR, Ostrand-Rosenberg S
Cancer Immunol Immunother. 2000 49 (1): 34-45

PMID: 10782864 · DOI:10.1007/s002620050024

MeSH Terms (17)

Animals Antigens, Neoplasm B7-1 Antigen Cancer Vaccines Cytotoxicity, Immunologic Female Histocompatibility Antigens Class II Immunotherapy Interferon-gamma Interleukin-12 Mammary Neoplasms, Experimental Mice Mice, Inbred BALB C Mice, Inbred C57BL Neoplasm Metastasis Neoplasm Transplantation T-Lymphocytes, Cytotoxic

Connections (2)

This publication is referenced by other Labnodes entities: